smgt glp 1 Smgt-glp-1 Nano Patch, Smgt Glp
Description
They provide integrated benefits including improved glycemic control, reduced albuminuria, lowering blood pressure, and weight loss
They redirected clinical questions to the in-app care team
New England Journal of Medicine 385896907
& Lee, Z-V
Zepbound is FDA-approved for chronic weight management with average weight loss of 18-21% body weight, while Trulicity is approved for type 2 diabetes management and cardiovascular risk reduction with modest weight loss of 4-10 lbs
As treatment extends beyond three years, clinicians must consider how gastrointestinal tolerability evolves over time
